Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 4INDUSTRY 2UNKNOWN 1OTHER_GOV 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 1Multiple Myeloma 1Meningioma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Kidney Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms, Male 1Breast Neoplasms 1Advanced Rare Tumours 1

Interventions

Radiotherapy 31Carboplatin 29Cisplatin 28Paclitaxel 26Gemcitabine 14Docetaxel 14Etoposide 13Bevacizumab 9Ramucirumab 7Pemetrexed 6Magnetic Resonance Spectroscopy 5Erlotinib Hydrochloride 5Cetuximab 5pembrolizumab 4cediranib 4Vinorelbine 4Specimen Handling 4Radiosurgery 4Gene Expression Profiling 4Filgrastim 4Amplified Fragment Length Polymorphism Analysis 4dexamethasone acetate 3dexamethasone 21-phosphate 3auricularum 3Surgical Procedures, Operative 3Radiotherapy, Conformal 3Psychiatric Rehabilitation 3Polymerase Chain Reaction 3Neoadjuvant Therapy 3Irinotecan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lung Neoplasms × Sunitinib × Clear all
NCT00953459 2018-07-26

Sunitinib Malate in Treating Patients With Small Cell Lung Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
9 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡